CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
The CVS Health Foundation has announced $525,000 in new Health Zones funding to support the Central California Food Bank's (CCFB) City Center Collaborative in Fresno. This initiative aims to improve health outcomes by enhancing access to healthy food and comprehensive support services. The funding will be distributed among several organizations, including CCFB's First Fruits Market, Family Healthcare Network, Fresno Mission, Central La Familia Advocacy Services, CASA, and Social Vocational Services.
The announcement was made during a Project Health event at City Center, where CVS Health offered free health screenings. In 2023, CVS Health hosted 170 Project Health events in California, screening 6,977 participants. The Health Zones initiative in Fresno focuses on addressing food insecurity, with 1 in 4 people and 1 in 3 children facing hunger in the area.
AM Best has revised the outlook to stable from positive for the Long-Term Issuer Credit Rating (Long-Term ICR) of Aetna Life Insurance Company and other Aetna Inc. subsidiaries, wholly owned by CVS Health (NYSE: CVS). The Financial Strength Rating (FSR) of A (Excellent) was affirmed. The revision reflects unfavorable operating trends in the first half of 2024, driven by:
- Increased utilization in Medicare Advantage
- Higher acuity in Medicaid due to redeterminations
- Changes in individual exchange business risk adjustment accrual
These factors led CVS Health to lower its full-year 2024 profit outlook. Despite expected near-term profitability, earnings are projected to improve in 2025 due to corrective actions. The ratings consider Aetna's very strong balance sheet, strong performance, favorable business profile, and appropriate risk management.
CVS Health reported Q2 2024 results and revised its full-year 2024 guidance. Total revenues increased 2.6% to $91.2 billion, while GAAP diluted EPS decreased to $1.41 from $1.48 in the prior year. Adjusted EPS fell to $1.83 from $2.21, primarily due to declining Health Care Benefits segment performance. The company revised its 2024 guidance, lowering GAAP diluted EPS to $4.95-$5.20 from at least $5.64, and Adjusted EPS to $6.40-$6.65 from at least $7.00. Cash flow from operations guidance was reduced to approximately $9.0 billion from at least $10.5 billion. The Health Care Benefits segment faced challenges, including increased utilization and unfavorable Medicare Advantage star ratings impact. In response, CVS announced leadership changes in this segment.
CVS Health (NYSE: CVS) is taking proactive measures to support customers, patients, members, and colleagues as Hurricane Debby makes landfall in Florida and moves through Georgia and the Carolinas. The company is implementing strategies across its business units to ensure continuity of care:
- CVS Pharmacy is reminding patients to refill prescriptions and stocking up on emergency supplies.
- CVS Caremark is enabling emergency prescription refills in affected areas.
- CVS Specialty is arranging alternate delivery for specialty medications.
- Aetna is expanding engagement with Medicare and Commercial members and offering liberalized Resources For Living services.
CVS Health is also supporting employees in affected areas and providing community resources. The company advises customers to follow local evacuation orders and take necessary precautions to ensure access to medications during the hurricane.
CVS Health has launched a groundbreaking initiative to support patients vulnerable to health impacts from extreme weather events, starting with heat waves. The program uses advanced environmental data analytics combined with patient medical and pharmacy data to provide personalized solutions. Initially available to Aetna members, with plans to expand to MinuteClinic and CVS Pharmacy locations, the initiative enables proactive outreach to at-risk patients up to seven days before an extreme weather event.
Care managers offer tailored recommendations, including directing patients to cooling centers, health services, and medication management. In its first two weeks, the program has connected with hundreds of at-risk patients across over 20 states. The initiative aims to improve health outcomes, reduce medical expenditures, and minimize hospital stays and emergency visits. It will expand in the fall to address air pollution-related health risks.
CVS Caremark, the leading pharmacy benefit manager and CVS Health company, has announced a renewed pledge to enhance transparency, reduce drug costs, and improve clinical care. The Caremark Client and Member Pledge focuses on:
1. Delivering greater affordability with an average out-of-pocket cost of less than $8 for a 30-day supply.
2. Promoting lowest net cost drugs.
3. Strengthening alignment between benefit design, physician choice, and patient need.
4. Innovating for greater transparency with the new TrueCost™ solution.
5. Encouraging pharmacy models that deliver rebate value directly to patients.
6. Improving relations with pharmacies.
7. Changing the trajectory of drug costs.
CVS Caremark aims to be a counterweight against pharmaceutical price hikes and continue putting medicine within reach for millions of Americans.
CVS Health announced that its Board of Directors has approved a quarterly dividend of $0.665 per share of Common Stock.
The dividend will be paid on August 1, 2024, to shareholders recorded by July 22, 2024.
CVS Health (NYSE: CVS) announced that it will hold a conference call with analysts and investors on Wednesday, August 7, 2024, at 8:00 a.m. ET to discuss its second quarter 2024 financial results.
The audio webcast of the event will be available live on the Investor Relations section of the CVS Health website and will be archived for one year. The call will provide insights into the company's financial performance and strategic initiatives.
CVS Health announced that President and CEO Karen S. Lynch and EVP and CFO Tom Cowhey will participate in the Bernstein 40th Annual Strategic Decisions Conference on May 29, 2024, at 10:00 am ET.
The event will include a fireside chat with investors.
An audio webcast of the event will be available live and archived for one year on the CVS Health Investor Relations website.
CVS Pharmacy has launched Well Market, a new store brand featuring 40 snacks, beverages, and groceries. The products are available nationwide and online. Well Market aims to offer nutritious and flavorful options, including innovative items like flavor-infused sprouted almonds. The line is designed to meet various dietary needs such as vegan, gluten-free, and keto. Existing brands Gold Emblem and Big Chill will be integrated under Well Market. Prices range from $2.99 to $8.99, and all products come with a 100% money-back guarantee. Packaging will be recyclable by 2030.